CDK4/6 inhibition disrupts this process, resulting in PD-L1 accumulation on the cell surface in TNBC and HR+/HER2− tumors, which may contribute to an immunosuppressive tumor microenvironment by promoting immune evasion. The gene discussed is CD274; the disease is neoplasm.